Author names and affiliations:
Maria Fernanda Badue Pereira1 PhD, Priscila
Suguita1 MD, Nadia Litvinov1 MD,
Sylvia Costa Lima Farhat2 PhD, Carolina dos Santos
Lázari3 MD, Juliana Valeria de Souza Framil¹ MD,
Camila Sanson Yoshino de Paula1 MSc, Pedro Vale
Bedê1 MD, Catarina Bueno1 MD,
Priscila Cristina Abduch Adas Branas1 MD, Irina
Monteiro da Costa Guimarães1 MD, Emilly Henrique dos
Santos4 BS, Marcia Marques Leite2MD, Ana Carolina B. Navega2 MD, Danilo Yamamoto
Nanbu2 MD, Claudio Schvartsman2 PhD,
João Renato Rebello Pinho3 PhD, Thelma Suely
Okay4 PhD, Clovis Artur A. Silva5PhD, Heloisa Helena de Sousa
Marques1 PhD.
1- Department of Pediatrics, Division of Pediatric Infectious Disease,
Instituto da Criança e do Adolescente (ICr), Hospital das Clínicas
HCFMUSP, São Paulo, Brazil.
2- Department of Pediatrics, Pediatric Emergence Division, Instituto da
Criança e do Adolescente (ICr), Hospital das Clínicas HCFMUSP, São
Paulo, Brazil.
3- Laboratório de Biologia Molecular, Hospital das Clínicas HCFMUSP, São
Paulo, Brazil.
4- Instituto de Medicina Tropical de São Paulo, Universidade de São
Paulo, Brasil.
5- Faculdade Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
Corresponding author: Maria Fernanda Bádue Pereira.
E-mail: maria.badue@hc.fm.usp.br
Av. Enéas Carvalho de Aguiar, 647 - Cerqueira Cesar
São Paulo-SP – Brazil zip code 05403-000
Phone: +55 11 2661 8673
Declarations of interest : both authors no conflict of interest.
Authors’ contribution: All the authors contributed
substantially to the conception and design of the study and in the
analysis and interpretation of data. All authors revised the work
critically and approved the final version.
Keywords: Child; COVID-19, SARS-CoV-2, rhinovirus
Abstract: The dynamic of SARS-CoV-2 and other respiratory virus
in children and adolescents is relevant in clinical context. There are
few studies comparing clinical course in COVID-19 (coronavirus disease)
and other respiratory virus in pediatric patients. The aim of this study
was to compare demographics and clinical features, exams abnormalities,
and outcomes in SARS-CoV-2 and other respiratory virus infections in a
pediatric population. This was a single-center prospective study,
between April 17 to September 30, 2020. We evaluated 76 pediatric
COVID-19 and 157 other respiratory virus infections. Rhinovirus occurred
in 132/157(84%). COVID-19 patients were significantly older, had more
fever (69% versus 50%; p=0.01), pneumonia (22% versus 5%;
p<0.01), myalgia (29% versus 8%; p=0.001), headache (31%
versus 14%; p=0.01) and worse outcomes than those with other
respiratory virus infections. Our data emphasizes differences in
clinical presentation and outcomes between pediatric COVID-19 and
rhinovirus infections.